Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lifecore Biomedical, Inc. \De\ (LFCR) Work In Process (2016 - 2018)

Historic Work In Process for Lifecore Biomedical, Inc. \De\ (LFCR) over the last 9 years, with Q4 2018 value amounting to $3.1 million.

  • Lifecore Biomedical, Inc. \De\'s Work In Process fell 3424.07% to $3.1 million in Q4 2018 from the same period last year, while for Nov 2018 it was $3.1 million, marking a year-over-year decrease of 3424.07%. This contributed to the annual value of $3.7 million for FY2018, which is 652.74% up from last year.
  • Lifecore Biomedical, Inc. \De\'s Work In Process amounted to $3.1 million in Q4 2018, which was down 3424.07% from $3.1 million recorded in Q3 2018.
  • Lifecore Biomedical, Inc. \De\'s Work In Process' 5-year high stood at $13.0 million during Q4 2016, with a 5-year trough of $1.9 million in Q2 2015.
  • In the last 5 years, Lifecore Biomedical, Inc. \De\'s Work In Process had a median value of $3.3 million in 2014 and averaged $3.8 million.
  • Its Work In Process has fluctuated over the past 5 years, first surged by 26568.54% in 2016, then plummeted by 6395.28% in 2017.
  • Lifecore Biomedical, Inc. \De\'s Work In Process (Quarter) stood at $4.0 million in 2014, then dropped by 11.86% to $3.6 million in 2015, then surged by 265.69% to $13.0 million in 2016, then plummeted by 63.95% to $4.7 million in 2017, then tumbled by 34.24% to $3.1 million in 2018.
  • Its last three reported values are $3.1 million in Q4 2018, $3.1 million for Q3 2018, and $3.7 million during Q2 2018.